Trastuzumab combined with chemotherapy for the treatment of HER2-positive metastatic breast cancer: pivotal trial data
(Q30659209)
scientific article
scientific article
Language:
Current Data About
Trastuzumab combined with chemotherapy for the treatment of HER2-positive metastatic breast cancer: pivotal trial data
| (P31) |
(Q13442814)
|
||||||||||||||||
| (P304) |
S57-62
|
||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||
| (P478) |
12 Suppl 1
|
||||||||||||||||
| (P577) |
Monday, January 1, 2001
|
||||||||||||||||
| (P921) |
(Q974135)
(Q12859063)
(Q412616)
|
||||||||||||||||
| (P1433) |
(Q326122)
|
||||||||||||||||
| (P1476) |
"Trastuzumab combined with chemotherapy for the treatment of HER2-positive metastatic breast cancer: pivotal trial data" (language: en)
|
||||||||||||||||
| (P2093) |
W Eiermann
International Herceptin Study Group
|
other details